Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding
Others
Ratios

Applied Therapeutics (APLT) Shares Outstanding (2023 - 2025)

Historic Shares Outstanding for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $144.3 million.

  • Applied Therapeutics' Shares Outstanding rose 2401.6% to $144.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.3 million, marking a year-over-year increase of 2401.6%. This contributed to the annual value of $137.2 million for FY2024, which is 6169.32% up from last year.
  • As of Q3 2025, Applied Therapeutics' Shares Outstanding stood at $144.3 million, which was up 2401.6% from $141.9 million recorded in Q2 2025.
  • In the past 5 years, Applied Therapeutics' Shares Outstanding registered a high of $144.3 million during Q3 2025, and its lowest value of $48.1 million during Q1 2023.
  • Over the past 3 years, Applied Therapeutics' median Shares Outstanding value was $114.8 million (recorded in 2024), while the average stood at $107.5 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 13744.2% in 2024, then soared by 2358.99% in 2025.
  • Over the past 3 years, Applied Therapeutics' Shares Outstanding (Quarter) stood at $84.9 million in 2023, then surged by 61.69% to $137.2 million in 2024, then grew by 5.15% to $144.3 million in 2025.
  • Its Shares Outstanding was $144.3 million in Q3 2025, compared to $141.9 million in Q2 2025 and $141.6 million in Q1 2025.